Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Nucleophilic Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102627590A details a mild route to chiral alpha-tribromomethyl amines. Offers high optical purity and scalable conditions for API intermediates.
Patent CN106146448A reveals efficient synthesis of chiral alpha-fluoro beta-amino ketones. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.